Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Adverum Biotechnologies stock

Learn how to easily invest in Adverum Biotechnologies stock.

Adverum Biotechnologies is a biotechnology business based in the US. Adverum Biotechnologies shares (ADVM) are listed on the NASDAQ and all prices are listed in US Dollars. Adverum Biotechnologies employs 188 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Adverum Biotechnologies stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ADVM. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Adverum Biotechnologies stock price (NASDAQ: ADVM)

Use our graph to track the performance of ADVM stocks over time.

Adverum Biotechnologies shares at a glance

Information last updated 2023-01-25.
Latest market close$0.69
52-week range$0.53 - $1.82
50-day moving average $0.65
200-day moving average $1.01
Wall St. target price$3.67
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.58

Buy Adverum Biotechnologies stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Adverum Biotechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adverum Biotechnologies price performance over time

Historical closes compared with the close of $0.694 from 2023-01-27

1 week (2023-01-23) 6.77%
1 month (2022-12-30) 19.66%
3 months (2022-10-28) -23.32%
6 months (2022-07-29) -52.47%
1 year (2022-01-27) -53.73%
2 years (2021-01-29) -94.37%
3 years (2020-01-30) 10.39
5 years (2018-01-30) 7.95

Adverum Biotechnologies financials

Gross profit TTM $-81,681,000
Return on assets TTM -22.93%
Return on equity TTM -56.36%
Profit margin 0%
Book value $2.09
Market capitalisation $66.8 million

TTM: trailing 12 months

Adverum Biotechnologies share dividends

We're not expecting Adverum Biotechnologies to pay a dividend over the next 12 months.

Adverum Biotechnologies share price volatility

Over the last 12 months, Adverum Biotechnologies's shares have ranged in value from as little as $0.531 up to $1.82. A popular way to gauge a stock's volatility is its "beta".

ADVM.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adverum Biotechnologies's is 0.7548. This would suggest that Adverum Biotechnologies's shares are less volatile than average (for this exchange).

Adverum Biotechnologies overview

Adverum Biotechnologies, Inc. , a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc.

Frequently asked questions

What percentage of Adverum Biotechnologies is owned by insiders or institutions?
Currently 3.672% of Adverum Biotechnologies shares are held by insiders and 62.781% by institutions.
How many people work for Adverum Biotechnologies?
Latest data suggests 188 work at Adverum Biotechnologies.
When does the fiscal year end for Adverum Biotechnologies?
Adverum Biotechnologies's fiscal year ends in December.
Where is Adverum Biotechnologies based?
Adverum Biotechnologies's address is: 800 Saginaw Drive, Redwood City, CA, United States, 94063
What is Adverum Biotechnologies's ISIN number?
Adverum Biotechnologies's international securities identification number is: US00773U1088
What is Adverum Biotechnologies's CUSIP number?
Adverum Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 05337G107

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site